Inflammatory cells infiltrating human colorectal carcinomas express HLA class II but not B7-1 and B7-2 costimulatory molecules of the T-cell activation

Laboratory Investigation

Volumn 74, Issue 5, 1996, Pages 975-983

  Chaux, Pascal ^a   Moutet, Monique ^a   Faivre, Jean ^a   Martin, François ^a   Martin, Monique ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 2;

ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; CELL INFILTRATION; COLORECTAL CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOLOGY; INFLAMMATORY CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ADENOCARCINOMA; ANTIBODIES, MONOCLONAL; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; COLORECTAL NEOPLASMS; CROHN DISEASE; DENDRITIC CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE ACTIVATION; MACROPHAGES; MEMBRANE GLYCOPROTEINS; NEOPLASM STAGING; T-LYMPHOCYTES;

EID: 0029937941     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Allen C and Hogg N (1985). Monocytes and other infiltrating cells in human colorectal tumors identified by monoclonal antibodies. Immunology 55:289-299.
2. Ambe K, Mori M, and Enjoji M (1989). S-100 protein-positive dendritic cells in colorectal adenocarcinomas. Cancer 63: 496-503.
3. Azuma M, Ito D, Yagita H, Okumura K, Phillips JH, Lanier LL, and Somoza C (1993). B70 antigen is a second ligand for CTLA-4 and CD28. Nature 366:76-79.
4. Banner BF, Savas L, Baker S, and Woda BA (1993). Characterization of the inflammatory cell populations in normal colon and colonic carcinomas. Virchows Archiv B Cell Pathol 64:213-220.
5. Beissert S, Hosoi J, Grabbe S, Asahina A, and Granstein RD (1995). IL-10 inhibits tumor antigen presentation by epidermal antigen-presenting cells. J Immunol 154:1280-1286.
6. Bodmer WF, Browning MJ, Krausa P, Rowan A, Bicknell DC, and Bodmer JG (1993). Tumor escape from immune response by variation in HLA expression and other mechanisms. Ann N Y Acad Sci 690:42-49.
7. Boise LH, Noel PJ, and Thompson CB (1995). CD28 and apoptosis. Curr Opin Immunol 7:620-625.
8. Chaux P, Hammann A, Martin F, and Martin MS (1993). Surface phenotype and functions of tumor-infiltrating dendritic cells: CD8 expression by a cell subpopulation. Eur J Immunol 23:2517-2525.
9. Csiba A, Whitwell HL, and Moore M (1984). Distribution of histocompatibility and leucocyte differentiation antigens in normal human colon and in benign and malignant colonic neoplasms. Br J Cancer 50:699-709.
10. Daar AS, Fuggle SV, Ting A, and Fabre JW (1982). Anomalous expression of HLA-DR antigen on human colorectal cancer cells. J Immunol 129:447-449.
11. Denfeld RW, Dietrich A, Wuttig C, Tanczos E, Weiss JM, Vanscheidt W, Schöpf E, and Simon JC (1995). In situ expression of B7 and CD28 receptor families in human malignant melanoma: Relevance for T cell-mediated antitumor immunity. Int J Cancer 62:259-265.
12. Ding L, Linsley PS, Huang LY, Germain RN, and Shevach EM (1993). IL-10 inhibits macrophages' costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J Immunol 151:1224-1234.
13. Dukes CE (1932). The classification of cancer of the rectum. J Pathol Bacteriol 35:323-332.
14. Enk AH, Angeloni VL, Udey MC, and Katz SI (1993). Inhibition of Langerhans cell antigen presenting cell function by IL-10. J Immunol 151:2390-2398.
15. Fearon ER (1992). Genetic alterations underlying colorectal tumorigenesis. Cancer Surv 12:119-136.
16. Fossum B, Breivik J, Meling GI, Gedde-Dahl T, Hansen T, Knutsen I, Rognum TO, Thorsby E, and Gaudernack G (1994). A K-ras 13Gly-> Asp mutation is recognized by HLA-DQ7 restricted T cells in a patient with colorectal cancer: Modifying effect of DQ7 on established cancers harboring this mutation? Int J Cancer 58:506-511.
17. Franklin WA, Mason DY, Pulford K, Falini B, Bliss E, Gatter KC, Stein H, Clarke L, and McGee JD (1986). Immunohistological analysis of human mononuclear phagocytes and dendritic cells by using monoclonal antibodies. Lab Invest 54:322-325.
18. Freedman AS, Freeman GJ, Rhynhart K, and Nadler LM (1991). Selective induction of B7/BB1 on interferon-γ stimulated monocytes: A potential mechanism for amplification of T-cell activation through the CD28 pathway. Cell Immunol 137:429-437.
19. Furue M, Nindl M, Kawabe K, Nakamura K, Ishibashi Y, and Sagawa K (1992). Epitopes for CD1a, CD1b, and CD1c antigens are differentially mapped on Langerhans cells, dermal dendritic cells, keratinocytes, and basement membrane zone in human skin. J Am Acad Dermatol 27:419-426.
20. Gastl GA, Abrams JS, Nanus DM, Oosterkam R, Silver J, Liu F, Chen M, Albino AP, and Bander NH (1993). Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression. Int J Cancer 55:96-101.
21. Gimmi CD, Freeman GJ, Gribben JG, Gray G, and Nadler LM (1993). Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. Proc Natl Acad Sci USA 90:6586-6590.
22. Harding FA, McArthur JG, Gross JA, Raulet DH, and Allison JP (1992). CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T cell clones. Nature 356:607-609.
23. Horn SS, Rosenberg SA, and Topalian SL (1993). Specific immune recognition of autologous tumor by lymphocytes infiltrating colon carcinomas: Analysis by cytokine secretion. Cancer Immunol Immunother 36:11-18.
24. Inaba K, Witmer-Pack M, Inaba M, Hatchock KS, Sakuta H, Azuma M, Yagita H, Okumura K, Linsley PS, Ikehara S, Muramatsu S, Hodes RJ, and Steinman R (1994). The tissue distribution of the B7-2 costimulator in mice: Abundant expression on dendritic cells in situ and during maturation in vitro. J Exp Med 180:1849-1860.
25. Janeway CA and Bottomly K (1994). Signals and signs for lymphocyte response. Cell 76:275-285.
26. Koch B, Giedl J, Hermanek P, and Kalden JR (1983). The analysis of mononuclear cell infiltrations in colorectal adenocarcinoma. J Cancer Res Clin Oncol 109:142-151.
27. Larsen CP, Ritchie SC, Hendrix R, Linsley PS, Hathcock KS, Hodes RJ, Lowry RP, and Pearson TC (1994). Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells. J Immunol 152:5208-5219.
28. Luebbers EL, Pretlow TP, Emancipator SN, Boohaker EA, Pitts AM, MacFadyen AJ, Bradley EL, and Pretlow TG II (1985). Heterogeneity and prognostic significance of macrophages in human colonic carcinoma. Cancer Res 45:5196-5200.
29. MacDermott RP and Stevenson WA (1988). Alterations of the immune system in ulcerative colitis and Crohn's disease. Adv Immunol 42:285-322.
30. Martin MS, Caignard A, Hammann A, Pelletier H, and Martin F (1987). An immunohistological study of cells infiltrating progressive and regressive tumors induced by two variant subpopulations of a rat colon cancer cell line. Int J Cancer 40:87-93.
31. Peetermans WE, D'Haens GR, Ceuppens JL, Rutgeerts P, and Geboes K (1995). Mucosal expression by B7-positive cells of the 60-kilodalton heat-shock protein in inflammatory bowel disease. Gastroenterology 108:75-82.
32. Poulter LW, Campbell DA, Munro C, and Janossy G (1986). Discrimination of human macrophages and dendritic cells by means of monoclonal antibodies. Scand J Immunol 24:351-357.
33. Pulford KAF, Sipos A, Cordell JL, Stross WP, and Mason DY (1990). Distribution of the CD68 macrophage/myeloid associated antigen. Int Immunol 2:973-980.
34. Schwartz RH (1992). Costimulation of T lymphocytes: The role of CD28, CTLA4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 71:1065-1068.
35. Shimizu Y, Iwatsuk S, Heberman RB, and Whiteside TL (1991). Effects of cytokines on in vitro growth of tumor-infiltrating lymphocytes obtained from human primary and metastatic liver tumors. Cancer Immunol Immunother 32: 280-288.
36. Skinner JM, Jarvis LJ, and Whitehead R (1983). The cellular response to human colonic neoplasms: Macrophage numbers. J Pathol 139:97-103.
37. Yamaguchi Y, Odoherty U, Peng M, and Steinman RM (1995). Difficulties in obtaining monoclonal antibodies to subsets of human leukocytes using neonatal tolerance induction in mice. J Immunol Methods 181:115-124.
38. Yoo YK, Heo DS, Hata K, Van Thiel DH, and Whiteside TL (1990). Tumor-infiltrating lymphocytes from human colon carcinomas: Functional and phenotypic characteristics after long-term culture in recombinant interleukin-2. Gastroenterology 98:259-268.